Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Debate intensifies over ban on puberty blockers and hormones for minors as Senate hears emotional testimony
Summary
CONCORD, N.H. — The Senate Health and Human Services Committee heard lengthy testimony on House Bill 377, a proposal to bar puberty blockers and cross‑sex hormones for minors, as supporters warned of long‑term developmental harms and opponents urged preservation of clinical judgment and parental choice.
CONCORD, N.H. — The Senate Health and Human Services Committee heard lengthy, at times emotional, testimony Tuesday on House Bill 377, a proposal to ban the prescription of puberty blockers and cross‑sex hormones for minors.
Sponsor Representative Lisa Mazur opened the hearing by describing the health‑policy rationale: she told senators puberty blockers such as Lupron were originally developed for other conditions and said their use in children “stop[s] puberty, stalling natural development of bones, the brain, and fertility.” Mazur and other proponents argued a lack of strong long‑term evidence and cited policy shifts in parts of Europe and other jurisdictions…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
